{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T13:08:10Z","timestamp":1750770490484,"version":"3.37.3"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"NICHD","doi-asserted-by":"publisher","award":["P50HD098580"],"award-info":[{"award-number":["P50HD098580"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["fertstertscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Science"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.xfss.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T16:15:44Z","timestamp":1722096944000},"page":"352-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype"],"prefix":"10.1016","volume":"5","author":[{"given":"Priyanka","family":"Saini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin G.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-8913","authenticated-orcid":false,"given":"J. Brandon","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-8599","authenticated-orcid":false,"given":"Debabrata","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfss.2024.07.008_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.xfss.2024.07.008_bib2","first-page":"100","article-title":"Uterine fibroids: diagnosis and treatment","volume":"95","author":"De La Cruz","year":"2017","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.xfss.2024.07.008_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.xfss.2024.07.008_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/humupd\/dmac008","article-title":"Epigenomic and enhancer dysregulation in uterine leiomyomas","volume":"28","author":"Mlodawska","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2024.07.008_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfss.2024.07.008_bib6","first-page":"275","article-title":"Uterine leiomyomata\u2014aetiology, symptomatology and management","volume":"225","author":"Buttram","year":"1986","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib7","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2024.07.008_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-\u03b23 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2024.07.008_bib9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor \u03b23 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.xfss.2024.07.008_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.matbio.2012.09.005","article-title":"Integrin \u03b21 regulates leiomyoma cytoskeletal integrity and growth","volume":"31","author":"Malik","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.xfss.2024.07.008_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2024.07.008_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.xfss.2024.07.008_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xfss.2024.07.008_bib14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xfss.2024.07.008_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03747-1","article-title":"Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma","volume":"596","author":"Berta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2024.07.008_bib16","first-page":"2114","article-title":"Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y","volume":"9","author":"Johnson","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.xfss.2024.07.008_bib17","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1016\/S0021-9258(19)38926-4","article-title":"The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure","volume":"265","author":"Reeves","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xfss.2024.07.008_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0092-8674(92)90554-P","article-title":"The High Mobility Group protein HMG I(Y) is required for NF-\u03baB-dependent virus induction of the human IFN-\u03b2 gene","volume":"71","author":"Thanos","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.xfss.2024.07.008_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1101\/SQB.1993.058.01.011","article-title":"The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex","volume":"58","author":"Thanos","year":"1993","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.xfss.2024.07.008_bib20","first-page":"775","article-title":"HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors","volume":"149","author":"Rogalla","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xfss.2024.07.008_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.xfss.2024.07.008_bib22","first-page":"1351","article-title":"Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15","volume":"63","author":"Quade","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00404-017-4515-5","article-title":"Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease","volume":"296","author":"Lagan\u00e0","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.xfss.2024.07.008_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/his.14732","article-title":"Histological and molecular analysis of cellular leiomyoma with sclerosis: linked to HMGA2 overexpression","volume":"81","author":"Griffin","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.xfss.2024.07.008_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gcc.20777","article-title":"HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas","volume":"49","author":"Markowski","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.xfss.2024.07.008_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/molehr\/gaq083","article-title":"HMGA proteins regulate the expression of FGF2 in uterine fibroids","volume":"17","author":"Helmke","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.xfss.2024.07.008_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/gcc.22643","article-title":"Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations","volume":"57","author":"Xie","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.xfss.2024.07.008_bib28","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1096\/fj.202000520R","article-title":"An HMGA2-p62-ER\u03b1 axis regulates uterine leiomyomas proliferation","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.xfss.2024.07.008_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.fertnstert.2020.05.036","article-title":"HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma","volume":"114","author":"Li","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2024.07.008_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/molehr\/gau114","article-title":"Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation","volume":"21","author":"Mas","year":"2015","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.xfss.2024.07.008_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108927","article-title":"Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution","volume":"34","author":"Leistico","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.xfss.2024.07.008_bib32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.xfss.2024.07.008_bib36","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/s41388-019-0808-4","article-title":"H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas","volume":"38","author":"Cao","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.xfss.2024.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3635","article-title":"A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression","volume":"8","author":"Holmes","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.xfss.2024.07.008_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xfss.2024.07.008_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.xfss.2024.07.008_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.xfss.2024.07.008_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"year":"2011","series-title":"DiffBind: differential binding analysis of ChIP-Seq peak data","author":"Stark","key":"10.1016\/j.xfss.2024.07.008_bib39"},{"key":"10.1016\/j.xfss.2024.07.008_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2024.07.008_bib41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41467-020-14701-6","article-title":"Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas","volume":"11","author":"Moyo","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.xfss.2024.07.008_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12859-018-2579-2","article-title":"NGmerge: merging paired-end reads via novel empirically derived models of sequencing errors","volume":"19","author":"Gaspar","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xfss.2024.07.008_bib43","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.xfss.2024.07.008_bib44","first-page":"1696-97","article-title":"MEME-ChIP: motif analysis of large DNA datasets","volume":"27","author":"Philip","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xfss.2024.07.008_bib45","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1038\/sj.onc.1208781","article-title":"A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells","volume":"24","author":"Caron","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.xfss.2024.07.008_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112831","article-title":"HMGA2 contributes to vascular development and sprouting angiogenesis by promoting IGFBP2 production","volume":"408","author":"Wang","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib47","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/cam4.1353","article-title":"LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p\/HMGA2 axis in breast cancer","volume":"7","author":"Zhao","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.xfss.2024.07.008_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/15384047.2020.1832429","article-title":"HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway","volume":"22","author":"Xu","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.xfss.2024.07.008_bib49","first-page":"398","article-title":"Downregulation of HMGA2 by small interfering RNA affects the survival, migration, and apoptosis of prostate cancer cell line","volume":"12","author":"Khajouee","year":"2022","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.xfss.2024.07.008_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfss.2024.07.008_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0037-1599090","article-title":"Recent advances in uterine fibroid etiology","volume":"35","author":"McWilliams","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.xfss.2024.07.008_bib52","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/ijms18112435","article-title":"Role of transforming growth factor \u03b2 in uterine fibroid biology","volume":"18","author":"Ciebiera","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xfss.2024.07.008_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.2001.6549","article-title":"Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display","volume":"84","author":"Pambuccian","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.xfss.2024.07.008_bib54","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/0008-5472.CAN-03-0560","article-title":"Decreased expression of early growth response-1 and its role in uterine leiomyoma growth","volume":"64","author":"Shozu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib55","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xfss.2024.07.008_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2024.07.008_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes","volume":"518","author":"Roadmap","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2024.07.008_bib58","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.celrep.2019.11.077","article-title":"Integrated epigenome, exome, and transcriptome analyses reveal molecular subtypes and homeotic transformation in uterine fibroids","volume":"29","author":"George","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.xfss.2024.07.008_bib59","doi-asserted-by":"crossref","DOI":"10.3791\/57320-v","article-title":"Promoter capture Hi-C: high-resolution, genome-wide profiling of promoter interactions","author":"Schoenfelder","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.xfss.2024.07.008_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.RES.0000134920.10128.b4","article-title":"Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1","volume":"95","author":"Takeda","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2009.05.050","article-title":"Transforming growth factor alpha induces angiogenesis and neurogenesis following stroke","volume":"163","author":"Leker","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.xfss.2024.07.008_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/biolre\/ioaa157","article-title":"Role of DNA damage and repair mechanisms in uterine fibroid\/leiomyomas: a review","volume":"104","author":"Toprani","year":"2021","journal-title":"Biol Reprod"},{"key":"10.1016\/j.xfss.2024.07.008_bib63","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/cr.2015.67","article-title":"High mobility group protein-mediated transcription requires DNA damage marker \u03b3-H2AX","volume":"25","author":"Singh","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12915-022-01375-3","article-title":"Hmga2 protein loss alters nuclear envelope and 3D chromatin structure","volume":"20","author":"Divisato","year":"2022","journal-title":"BMC Biol"},{"key":"10.1016\/j.xfss.2024.07.008_bib65","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fendo.2020.00556","article-title":"Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer","volume":"11","author":"Ku","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xfss.2024.07.008_bib66","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.18632\/oncotarget.23652","article-title":"MMP2-A2M interaction increases ECM accumulation in aged rat kidney and its modulation by calorie restriction","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.xfss.2024.07.008_bib67","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.xfss.2024.07.008_bib68","doi-asserted-by":"crossref","first-page":"e1517","DOI":"10.1210\/clinem\/dgz227","article-title":"Activation of \u03b2-catenin signaling and its crosstalk with estrogen and histone deacetylases in human uterine fibroids","volume":"105","author":"Ali","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfss.2024.07.008_bib69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12958-021-00790-5","article-title":"5-aza-2\u2032-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt\/\u03b2-catenin pathway in human uterine leiomyomas","volume":"19","author":"Carbajo-Garc\u00eda","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xfss.2024.07.008_bib70","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1933719111398147","article-title":"Histone deacetylase 6 regulates estrogen receptor alpha in uterine leiomyoma","volume":"18","author":"Wei","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.xfss.2024.07.008_bib71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/09513590.2017.1301924","article-title":"Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells","volume":"33","author":"Sant\u2019Anna","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.xfss.2024.07.008_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1095\/biolreprod.115.134924","article-title":"The polycomb group protein EZH2 impairs DNA damage repair gene expression in human uterine fibroids","volume":"94","author":"Yang","year":"2016","journal-title":"Biol Reprod"},{"key":"10.1016\/j.xfss.2024.07.008_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/1568026615666150825125857","article-title":"Histone and non-histone targets of dietary deacetylase inhibitors","volume":"16","author":"Kim","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.xfss.2024.07.008_bib74","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/cas.14840","article-title":"The noncanonical role of EZH2 in cancer","volume":"112","author":"Huang","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.xfss.2024.07.008_bib75","first-page":"775","article-title":"Oncological role of HMGA2 (review)","volume":"55","author":"Zhang","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.xfss.2024.07.008_bib76","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-021-03217-z","article-title":"Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases","volume":"480","author":"Dundr","year":"2022","journal-title":"Virchows Arch"},{"issue":"suppl","key":"10.1016\/j.xfss.2024.07.008_bib77","first-page":"159","article-title":"The cellular physiology of carbonic anhydrases","volume":"2","author":"Breton","year":"2001","journal-title":"JOP"},{"key":"10.1016\/j.xfss.2024.07.008_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063909","article-title":"Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35)","volume":"8","author":"Davis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xfss.2024.07.008_bib79","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-07-6339","article-title":"Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia","volume":"68","author":"Mayer","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.xfss.2024.07.008_bib80","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.3390\/ijms21093151","article-title":"High Mobility Group AT-Hook 2 (HMGA2) oncogenicity in mesenchymal and epithelial neoplasia","volume":"21","author":"Unachukwu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xfss.2024.07.008_bib81","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/cancers14061480","article-title":"The Fra-1\/AP-1 oncoprotein: from the \u201cundruggable\u201d transcription factor to therapeutic targeting","volume":"14","author":"Casalino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xfss.2024.07.008_bib82","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1210\/en.2017-03191","article-title":"The AKT\/BCL-2 axis mediates survival of uterine leiomyoma in a novel 3D spheroid model","volume":"159","author":"Vidimar","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfss.2024.07.008_bib83","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfss.2024.07.008_bib84","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: targeting epigenetic marks in cancer treatment","volume":"14","author":"Miranda Furtado","year":"2019","journal-title":"Epigenetics"}],"container-title":["F&S Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X24000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X24000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:13:21Z","timestamp":1732295601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666335X24000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666335X24000430"],"URL":"https:\/\/doi.org\/10.1016\/j.xfss.2024.07.008","relation":{},"ISSN":["2666-335X"],"issn-type":[{"type":"print","value":"2666-335X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype","name":"articletitle","label":"Article Title"},{"value":"F&S Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfss.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}